ENvue Medical (FEED) Liabilities and Shareholders Equity (2014 - 2026)
ENvue Medical's (FEED) quarterly Liabilities and Shareholders Equity came in at $39.9 million in Q1 2026, down 9.6% year-on-year from $44.1 million in Q1 2025, and down 3.05% on a QoQ basis from $41.1 million in Q4 2025.
ENvue Medical (FEED) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends
ENvue Medical (FEED) has 13 years of Liabilities and Shareholders Equity data on file, last reported at $39.9 million in Q1 2026.
- On a quarterly basis, Liabilities and Shareholders Equity fell 9.6% year-over-year to $39.9 million in Q1 2026; TTM through Mar 2026 was $186.9 million, a 221.55% increase from a year earlier, with the FY2025 full-year figure at $41.1 million, up 1033.2% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $39.9 million, down from $41.1 million in the prior quarter.
- Over the last five years, Liabilities and Shareholders Equity for FEED reached as high as $54.4 million in Q3 2025 and fell as low as $3.6 million in Q4 2024.
- Historically, Liabilities and Shareholders Equity has averaged $17.6 million across 5 years, with a median of $6.5 million in 2022.
- Across the five-year window, Liabilities and Shareholders Equity tumbled 46.1% in 2022 and jumped 1061.53% in 2025, its largest moves.
- Year by year, Liabilities and Shareholders Equity stood at $5.9 million in 2022, then grew by 13.52% to $6.7 million in 2023, then tumbled by 45.62% to $3.6 million in 2024, then surged by 1033.2% to $41.1 million in 2025, then slipped by 3.05% to $39.9 million in 2026.
- Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $39.9 million in Q1 2026, $41.1 million in Q4 2025, and $54.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.86 Bn | 175.56 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 108.31 Bn | 99.09 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 48.25 Bn | 44.58 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 6.63 Bn |
| 7 | GE HealthCare Technologies | 28.05 Bn | 25.76 Bn | 1.98 Bn | 37.13 Bn |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - | 10.46 Bn |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 31.92 Bn |
| 10 | ENvue Medical | 1.20 Mn | -1.06 Mn | -55,000.00 | 39.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.87 Mn |
| Dec 31, 2025 | 41.12 Mn |
| Sep 30, 2025 | 54.38 Mn |
| Jun 30, 2025 | 51.48 Mn |
| Mar 31, 2025 | 44.11 Mn |
| Dec 31, 2024 | 3.63 Mn |
| Sep 30, 2024 | 4.68 Mn |
| Jun 30, 2024 | 5.70 Mn |
| Mar 31, 2024 | 6.24 Mn |
| Dec 31, 2023 | 6.67 Mn |
| Sep 30, 2023 | 7.36 Mn |
| Jun 30, 2023 | 3.83 Mn |
| Mar 31, 2023 | 4.81 Mn |
| Dec 31, 2022 | 5.88 Mn |
| Sep 30, 2022 | 5.21 Mn |
| Jun 30, 2022 | 6.54 Mn |
| Mar 31, 2022 | 7.66 Mn |
| Dec 31, 2021 | 8.62 Mn |
| Sep 30, 2021 | 9.67 Mn |
| Jun 30, 2021 | 6.83 Mn |